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Abstract
Trauma or repeated injury to the joint can result in focal cartilage defects, which significantly
increases the risk of osteoarthritis. Cartilage being avascular has limited self-healing capacity.
The current method for treating cartilage defects at early stages involves implantation of
autologous chondrocytes with or without a scaffold through invasive surgery; however,
invasive surgery can bring pain to patients and post-operative infection risks. Therefore,
injectable and biodegradable biomaterials have piqued people's interest. In the current research,
we designed a hybrid double network (DN) cryogel by combining multi-arm PEG acrylate and
alginate as two networks and crosslinking them at -20°C. Through different characterizations
(SEM, mechanical strength, swelling test, etc.), we found that the DN cryogel has a
macroporous interconnected structure, high water uptake capacity, and can support
chondrocyte growth and extracellular matrix synthesis. These features make it possible for the
cryogel to be used as a scaffold for cartilage to treat cartilage defects.
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Chapter 1
Cryogels synthesis and characterization
1. Introduction
1.1. Cartilage
1.1.1. Architecture of cartilage and effect of cartilage defect on joint health
Articular cartilage is a kind of smooth surface that covers the end of the femur and the tip
of the tibia. Its function is to help smooth movement of the sliding joint surface, and it can also
buffer the end of the bone through weight-bearing.1 In contrast to most tissues, articular
cartilage has no blood vessels, lymphatic vessels, or nerves. It consists of a dense extracellular
matrix (ECM) and sparsely distributed chondrocytes. The ECM is mainly composed of water,
proteoglycans, and collagen, with lesser amounts of other non-collagen and glycoproteins.2
Together, these components help retain moisture in the ECM, which is critical for maintaining
its mechanical properties. Articular cartilage damage is thought to be the cause of serious
musculoskeletal disorders. Articular cartilage is structurally complex and cannot be
regenerated, making it challenging to treat and repair cartilage in patients with cartilage defects.
Since cartilage has no vascular structure, damaged cartilage has limited ability to heal and
repair. Therefore, repairing the normal structure and function of damaged cartilage is one of
the most challenging areas in orthopedic research and sports medicine.3
Defects in articular cartilage may be due to natural degeneration with age, repeated wear
and tear caused by sports, or traumatic events, such as knee abrasions, injuries from jumping
from a height, or spraining the knee. Sometimes these injuries are also related to knee fractures
or ligament injuries. Occasionally, because there are no nerve endings in the cartilage, these
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injuries do not always immediately cause pain. However, patients may experience swelling,
stiffness, and mechanical symptoms. Pain may be related to other injuries that occur, such as
fractures, bone contusions, ligament injuries, or other severe articular cartilage injuries.4-5
When a cartilage defect is confined to a specific area within the joint, it is called a focal articular
cartilage defect. Focal articular cartilage defects’ symptoms include pulsation, pain, swelling,
tenderness, and restricted mobility.6 The degree of articular cartilage damage can range from
surface softening to full-thickness bone defects. In addition, the type of damage is also
measured by the size of the defect. As the thickness and defect area increase, the size and depth
of the defect tend to increase over time. Since cartilage is avascular, it has limited self-healing
abilities. In terms of the depth and size of the defect, generally, more severe injuries may
require surgery to replace or repair the defect.7
1.1.2. Cartilage defect statistic
Defects of focal cartilage injuries are extremely common, and lesions are frequently
detected via arthroscopy, even in asymptomatic individuals. Two studies reviewing the
incidence of focal cartilage lesions reported the presence of focal lesions in 60-63% of
individuals undergoing arthroscopies. The disease burden for the cartilage lesions has tripled
from 1996 to 2011 across all gender and age groups. The percentage of patients being treated
for cartilage injuries has increased from 13.8 to 22.1%, but less than 1% of these get advanced
treatment like chondrocyte transplantation.8-9
The high joint injury rates, combined with the inability of the cartilage to heal itself, leaves
the patients at high risk of developing osteoarthritis (OA). Osteoarthritis (OA) is currently one
of the widespread chronic diseases in the world. Among people 20 years and older, the global
incidence of knee OA is 203 per 10,000 people per year.10 Correspondingly, by 2020,

3

approximately 86.7 million people 20 years and older worldwide will suffer from knee arthritis
each year.10 The incidence in the United States is 130 cases per 10,000 people per year.10 The
chance of developing OA increases with age (Figure 1). OA is generally regarded as a nonserious disease because it does not cause a fatal impact on humans in the short term, but it has
a significant impact on patients and their families, and its impact is long-term. The
socioeconomic burden of OA is huge. It leads to the development of chronic disability and pain
in the affected individual. Thus, early and advanced treatment of joint injuries can prevent or
reduce the risk of OA in individuals.

Figure 1. The prevalence of knee osteoarthritis changes with age. Figure is adapted from CDC
website.
1.1.3. Traditional treatment for articular cartilage defect
Clinical treatments for localized cartilage defects include arthroscopic debridement,
arthroscopic microfracture, Osteochondral Autograft Transplantation (OATS),11 Autologous
Chondrocyte Implantation (ACI)4, and Osteochondral Allograft. The most common clinical
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treatment for focal cartilage defects is arthroscopic chondroplasty or arthroscopic debridement.
Arthroscopic debridement, an option to treat cartilage defects, uses a razor to remove loose
joint fragments to help smooth the joint defect, thereby improving, but not completely
normalizing, the sliding surface. While this procedure provides short-term relief, it makes
cartilage more susceptible to wear and tear. Another way to solve cartilage defects is
arthroscopic microfracture, making small perforations in the subchondral bone. This allows
some blood/bone marrow cells to enter into the defect. This bone marrow enables repair of the
defect, thereby forming a new fibrocartilage, which is mostly mechanically inferior compared
to original cartilage. In mosaicplasty or osteochondral autograft transplantation (OATs), the
core of articular cartilage and bone is removed from another part of the knee joint and
transferred to the articular cartilage defect for repair. The OATs procedure results in donor site
morbidity, poor integration and degeneration of implanted cartilage over time.12
More advanced methods of cartilage regeneration include autologous chondrocyte
implantation (ACI), matrix-associated autologous chondrocyte (MACI), and autologous
matrix-induced chondrogenesis (AMIC). Both ACI and MACI are two-step procedures in
which a piece of articular cartilage is removed through arthroscopy. The piece of cartilage is
sent to the laboratory where the cells in the cartilage tissue are separated and cultured to
multiply cells to increase the overall number of cells. Later, in ACI, these cells will be reimplanted into the articular cartilage defect of the knee joint. In cases of MACI, the harvested
cells from the chondrocyte are expanded in a collagen-based matrix and then re-implanted into
the defect site. AMIC, on the other hand, is a single-step procedure that includes implantation
of a collagen-based matrix into the defect site in combination with microfracture.13 These
advanced treatments ACI, MACI and AMIC– have shown improved outcomes compared to
more traditional treatments. Lastly, osteochondral allograft involves using a piece of cartilage
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and bone removed from a cadaveric knee joint. This bone and cartilage are then implanted into
the cartilage and bone defect through open surgery in the knee joint.14 In spite of the high
incidence of chondral defects, the number of patients undergoing any type of arthroscopic
procedure, traditional or advanced, was only 93/100,000 in 2011.15 In contrast, patients
undergoing total knee arthroplasty (TKA) is fairly high, 429/100,000.15 Total knee arthroplasty
(TKA)11 remains the most common surgical treatment for arthritis of the knee. The huge
disparity between the number of TKA surgeries and articular cartilage repair surgeries indicates
an unmet need for better clinical treatments for chondral defects, which can prevent the
development of end-stage OA and avoid the need for TKA.16

1.2. Tissue engineering strategies to solve cartilage defect
Several cartilage repair methods require surgery and cartilage transplantation. Many of
these methods are associated with pain, long postoperative recovery, high morbidity, high cost,
and inflammation of the donor sites. Tissue engineering offers a promising alternative strategy
by engrafting chondrocytes into biocompatible scaffolds to produce engineered cartilage for
repairing damaged cartilage. Tissue engineering can not only help avoid surgery, but also
reduce patient suffering and improve clinical outcomes.17
1.2.1. Scaffolds for cartilage tissue engineering
Cartilage tissue engineering involves both scaffold-free and scaffold-assisted promotion
of neocartilage formation. Scaffold-free techniques mainly rely on generation of cellular
aggregates by culturing chondrocytes on non-adherent cultures. These cellular aggregates not
only maintain the spherical shape of cells, similar to native cartilage, but also promote cell-tocell contact and generation of neocartilage with biomechanical and biochemical properties
similar to native cartilage. Some of these technologies are in advanced states of clinical trials.
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However, in spite of these successes, tissue integration with surrounding cartilage is a challenge
yet to be overcome.18
Scaffolds play an important role in cartilage tissue engineering. Some of the desired
features for a scaffold for cartilage tissue engineering are 1) coordinating scaffold
biodegradation and neocartilage growth rate; 2) removal of scaffold byproducts, such as acidic
products of degradation; for example, when using poly esters like polyglycolic acid (PGA); 3)
biocompatibility of scaffolds; for example, the removal of residual chemicals of scaffold
processing, which may be harmful for the cells;19 4) incorporating design parameters that allow
chondrocytes to maintain spherical morphology similar native chondrocytes;19-20 5) mimicking
the compressive surface and tensile properties of cartilage. Any mismatch in mechanical
properties of implant vs. native cartilage leads to poor integration and shredding of the
implanted scaffold due to an imbalance in force distribution. These scaffold-forming materials
should also be able to withstand in vivo conditions such as pH and body temperature.21-22
Several scaffolds made of natural and synthetic polymers have been tested as matrix
systems for culture of chondrocytes and other chondrogenic cells, such as mesenchymal stem
cells. Collagen, hyaluronic acid (HA), chitosan (CH), chondroitin sulfate (CS) and other natural
materials, such as fibrin, have been shown to be widely used to produce scaffolds for cartilage
regeneration. These materials are characterized by biological activity and strong
biocompatibility.23-24 Several scaffolds based on collagen,25-29 chitosan,30-31 and hyaluronic
acid32-34 are commercially available and have shown improved clinical outcomes in MACI.
However, natural materials are not mechanically stable enough to support cells, so their use as
scaffolds produces products that are not sufficient to regenerate tissue.35-36 Some popularly
used synthetic polymers for cartilage tissue engineering are polyesters like poly(lactic-coglycolic acid) (PLGA),37-38 polylactic acid (PLA),39-40 polyglycolic acid (PLG), polyethylene

7

glycol (PEG),41-42 polyurethane (PU),43 and polycaprolactone (PCL).24, 43-44 Compared with
natural materials, synthetic polymers can be used to produce membranes of different shapes by
a variety of techniques and, at the same time, can provide better mechanical properties. 35-36
Most of these polymers can be degraded into components that are metabolized in the body after
use. Furthermore, by combining these polymers (as copolymers or blends), the mechanical
properties and degradation times of the polymers can be controlled.35-36 However, synthetic
materials lack cell adhesion ligands, and degradation products, such as acidic byproducts, can
have adverse effects on the site of implantation.35-36 Recently, there has been great interest in
generating hybrid scaffolds combining two different polymers or synthetic and natural
polymers. Hybrid scaffolds, combining synthetic and natural polymers allow them to obtain
scaffolds of higher mechanical properties than a single network and retain the advantages of
natural materials such as cell adhesion sites and biocompatibility, as required for cartilage
regeneration.35-36
Blends of natural and synthetic polymers have been combined by a variety of methods
such as freeze casting, phase separation, porogen leaching and, more recently, 3D printing to
generate a variety of scaffolds with an open and interconnected network of pores. Further
expanding the use of polymers crosslinked hydrogels have gained a lot of interest for
generating appropriate scaffolds for cartilage tissue engineering.45
1.2.2. Interpenetrating network of hybrid hydrogels for cartilage tissue engineering
Hydrogels are a crosslinked network of polymers that are highly swollen in aqueous
environments whereby 90% of weight is water. Various parameters of hydrogel formation can
be tuned. These include crosslinking density, degradation rate, and inclusion of bound or free
biochemical factors. Numerous studies have shown promising outcomes when chondrocytes
are cultured in 3-D hydrogels.36, 46 One advantage is the high content of water in hydrogels,
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which is similar to native cartilage. An important design parameter for hydrogels to be used for
cartilage tissue engineering is mechanical integrity. Traditional single-network hydrogels lack,
or are mechanically weak, and thus may not be a suitable scaffold for generating cartilage.
Toward advancing the use of hydrogels for cartilage tissue engineering and meeting the
requirements of enhanced mechanical strength matching that of native cartilage, hydrogels are
being made using multiple polymers.46-47 Hydrogels made of multiple polymers have far
superior mechanical integrity compared to any single network hydrogels that may facilitate
better integration with surrounding tissue.

In this regard, interpenetrating networks of

hydrogels made up of two or more polymer networks have been used for cartilage tissue
engineering. For instance, Ingavle et al.48 incorporated methacrylate chondroitin sulfate as a
second network in an agarose-PEG diacrylate hydrogel network. Incorporation of chondroitin
sulphate increased the viability of encapsulated chondrocyte and ECM matrix deposition.
Another example of a hybrid IPN network is reinforcement of fibrin gels with methacrylated
hyaluronic acid (HA). The incorporation of HA increased expression of chondrogenic markers
by mesenchymal stem cells.49
A special type of interpenetrating networks called double-network (DN) hydrogels have
attracted a lot attention due to their exceptional toughness and mechanical strength that can
mimic native hyaline cartilage.50-53 Tough DN hydrogels consist first of a network forming a
rigid structure while a second network is soft and ductile. A DN is synthesized by a two-step
sequential radical polymerization of the two polymer networks.54 Typical polymers used for
DN hydrogels consist of a combination acrylamide polyelectrolytes poly(2-acrylamido-2methylpropanesulfonic acid) (PAMPs) or poly(N,N-dimethylacrylamide) with neutral
acrylamide polymers like polyacrylamide.51, 55 More recently, natural polymer like hyaluronic
acid and gelatin has been combined to generate double network hydrogels for cartilage tissue
engineering.56 During polymerization, the rigid and brittle polymer network forms a tightly
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cross-linked network structure with a high overall cross-linker concentration. This brittle
polyelectrolyte hydrogel is fully swollen in a high-concentration neutral monomer aqueous
solution containing a lower concentration of a cross-linking agent, and then the second
monomer polymerizes with the network structure to form a flexible network inside the first
network hydrogel.54 Recent in vivo studies using DN hydrogels for cartilage regeneration show
increase in sulphated glycsoaminoglycans (GAGs) and type 2 collagen, the typical components
of native, healthy cartilage.56-58 However, owing to a very high crosslinking density and nondegradability of the DN hydrogels, no cell infiltration is observed. Polymers used for DN
hydrogels are often non-degradable, which renders DN hydrogels impermeable to cells and, in
the long-term, limit deposition of ECM.47
A variation of DN hydrogels, which has been developed recently, is a hybrid gel consisting
of a covalently crosslinked network interpenetrating with an ionically linked network of natural
polymers. The combination of these two networks as IPN results in a highly tough, stretchable
and self-healing hybrid hydrogels. The replacement of one of the covalent networks with noncovalent ionically crosslinked network allows for recoverable energy dissipation and selfhealing of the gel after a certain delay. Unlike DNs with two covalent networks, these hybrid
gels retain fracture toughness on repeated loading.59 A hybrid interpenetrating network of PEG
diacrylate and sodium alginate crosslinked via free radical crosslinking and ionic crosslinking,
respectively. The hybrid IPN exhibited high fracture toughness and stretchability, which
exceeded natural cartilage. The hydrogels maintained high cell viability and promoted the
expression of ECM.60 Some other polymers that have been used to form the non-covalent
network in these hybrid double network gels include polyvinyl alcohol, chitosan, and agar etc
while the covalent network is exclusively formed via free-radical crosslinking of acrylamide
or PEG diacrylate.61-63 However, the use of a covalent network formed via free radical
crosslinking makes these hybrid DN gels non-degradable. Moreover, with the exception of a
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few examples, most hybrid DN gels are non-porous in nature. These limit the application of
hybrid DN gels for cartilage tissue engineering. Several studies have shown that porous
structure and degradability are important for cell infiltration and ECM matrix deposition for
cartilage constructs.64-65
In this study, we aim to overcome the limitation of current hybrid DN gels by generating
ice-template, hybrid macroporous double network cryogels of PEG and alginate using
biocompatible click chemistry for covalent network formation and ionic non-covalent bonding
in alginate networks.
1.2.3. Definition of cryogels
Cryogels are macroporous hydrogels, which are made at sub-zero temperatures. The
process of generating cryogels is essentially different than the typical freeze-drying process for
generating macroporous hydrogels. To make cryogels, gel precursors along with crosslinkers
are mixed and then frozen at sub-zero temperatures (typically -5°C to -20°C). The gel
precursors undergo chemical or physical crosslinking in a frozen state. 66-67 The main stage of
cryogel synthesis is in the freezing state, during which chemical reactions take place leading to
gelation. During the freezing process, most of the solvents crystallize by freezing. These
solvent crystals can act as porogens, while the hydrogel components remain in the liquid
microphase around them. A cryogel with an open, interconnected macroporous structure is
formed upon the thawing and melting away of the ice crystals.68-71
The freezing rate significantly affects the pore size and porosity of cryogels. Slower
freezing rates may result in larger pores and increased structural interconnectivity. In contrast,
faster freezing rates produce cryogels with weaker mechanical strength and lower levels of
pore interconnection. This may be because at very low temperatures the ice nuclei generated
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are very small and do not grow enough to generate interconnected pore networks.72-76
Furthermore, the resulting network is spongy, mechanically stable, and can be compressed to
at least half its length without damage.77-79 After hydration, cryogel pores become rounded due
to the liquid and surface tension of the pore walls. In addition, the macroporous structure
facilitates rapid swelling and homogenous cellular infiltration. The physical properties of
cryogels, especially pore size, can be influenced by adjusting parameters such as polymer
content and concentration, crosslinker mechanism and concentration, freezing time,
temperature and freezing/thawing cycles.69, 80-85 To confirm that cryogels have the appropriate
properties for application to a particle tissue, typical characterization of cryogels includes
analysis of pore size and overall degree of interconnectivity. Mechanical durability is also
assessed by a combination of compression and tensile tests.
1.2.4. Cryogels for cartilage tissue engineering
DN (double network) cryogels and SN (single network) cryogels: Single network cryogels
are gels synthesized from only one polymer at sub-zero temperature. Compared with singlenetwork cryogels, interpenetrating network69, 81-83, 85-86 and double-network cryogels are gels
synthesized from two kinds of polymers at sub-zero temperature.87-90 DN cryogels usually
tend to have stronger mechanical strength.91-92
In this study, we designed hybrid double network cryogels with interconnected
macroporous structures that provide a favorable environment for chondrocyte adhesion,
proliferation, and matrix formation. We first synthesized hybrid double network and single
network cryogel scaffolds based on multi-arm PEG acrylate with and without alginate and then
performed a series of characterizations to assess the internal structure, mechanical strength,
water uptake capacity and degradation of cryogels. Finally, we assessed the suitability of the
cryogels for culturing mouse-knee derived chondrocytes in the cryogels. Our results indicate
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the hybrid double network cryogels with macroporous interconnected structure can provide a
suitable scaffold for culture of primary chondrocytes.

2. Materials and methods
2.1. Overview
We first synthesized hybrid DN (double network) cryogels, using sodium alginate as one
of the networks with multi-arm PEG acrylate (4 arm PEG acrylate (MW:10kDa) or 8 arm PEG
acrylate (MW: 10kDa)) as the second network. The multi-arm PEG acrylate network was
crosslinked via a dithiol crosslinker (Dithiothreitol (DTT), Dithiobutylamine (DTBA) or PEG
dithiol.) using Michael addition chemistry between thiol and acrylate. A combination of
different dithiol crosslinker and multi-arm PEG acrylate generated a crosslinked network with
different density of thioester bonds, which led to different degradation rates of the network.
The hybrid DN cryogels were characterized for pore structure, mechanical properties, the
degradation rate, and the equilibrium swelling rate. Finally, chondrocytes were seeded onto the
hybrid DN cryogels and analyzed for sulfated glycosaminoglycan (sGAG) synthesis.

2.2. Hybrid DN cryogels synthesis
Alginate-PEG DN cryogels were synthesized by combining multi-arm PEG acrylates with
di-thiol crosslinkers, while alginate was combined with calcium salt and were freezed for a
specified length of time. First 20 % w/v solution of multi-arm PEG was mixed with 1% w/v
alginate solution made in 0.01 M HEPES buffer of pH 7.2. Next, the calcium carbonate
(0.03M) and glucono-delta-lactone (GDL) (0.06M) (molar ratio of CaCO3: GDL is 1:2) was
added to the mix to initiate the crosslinking of the alginate network. Finally, a dithiol
crosslinker (DTT, DTBA or PEG dithiol) was added to the mix in a 1:1 molar ratio of acrylate:
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thiol. All preparation of gel precursor solutions was done over ice to maintain low temperatures
and to prevent any premature gelation before the precursor solution was frozen. Once all
crosslinkers were added, the solution was quickly transferred into a plastic vial. The vial was
sealed and placed in a cryostat set at -20°C and maintained in a frozen state for 18 hours to
allow for complete gelation (Figure 2). After incubation the cryogels were thawed at room
temperature and washed with water to remove any unreacted precursors. The macroporous
cryogels obtained are freeze dried for further use. The different precursors used for DN cryogel
preparation and their concentration are listed in Table 1 and Table 2 below.

Figure 2. Synthesis of Alginate- PEG hybrid DN (double network) cryogels.
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Table 1. Structure and properties of multi arm PEG Acrylate.
Network

Abbreviation

MW
(Da)

4 arm PEG acrylate

4-arm PEGAc

10k

8 arm PEG acrylate

8-arm PEGAc

10k

Structure

Table 2. Structure and properties of dithiol crosslinkers used for the synthesis of PEG network
in hybrid DN cryogels.
Crosslinker

Abbreviation

MW (Da)

PEG dithiol

PEG-diSH

3400

Dithiolerthritol

DTT

154

(S)-2 Aminobutane 1,4 dithiol

DTBA

177

Structure

2.3. Characterization of DN cryogels
2.3.1. Scanning Electron Microscopy
Scanning electron microscopy (SEM) analysis was performed on different double network
cryogels and single network cryogels. All samples were dried in ethanol gradient.93 The
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samples were cut into 5 mm height discs and placed into ethanol with increasing
concentrations(20 %, 40 %, 60%, 80 % v/v) for 5 minutes each. Finally, the samples were
placed in 100% (v/v) ethanol for 30 minutes for complete dehydration. The samples were then
vacuum dried overnight using a lyophilizer before gold plating. Dried and gold coated cryogels
were imaged using JEOL JSM 5600 SEM.
2.3.2. Fourier-transform infrared spectroscopy
Fourier-transform infrared spectroscopy (FTIR) analysis was performed on different
double network cryogels and single network cryogels. All samples were dried in a gradient of
ethanol as described for SEM microscopy. The dried cryogels were placed in an FTIR
instrument (Thermo IS5) for testing, to obtain an infrared spectrum. Each spectrum was
recorded in the range of 500 to 4000 cm-1 at a resolution of 4 cm-1 and 64 scans per spectra.
The chemical composition of cryogels was inferred by the relative positioning of the peaks in
the FTIR spectrum.
2.3.3. Mechanical strength
Universal compression and tensile tester was used to perform tensile and compression tests
on DN cryogels and SN cryogels (Figure 3). In the tensile test, a sample with a diameter of 12
mm and a length of 2.5 mm was placed between two clamps, and the cryogels were stretched
at a speed of 2 mm/sec until the sample was broken. The tensile force was recorded, and the
change in sample length caused by the stretching was measured.
In the compression test, a sample with a diameter of 12 mm and a length of 5 mm was
placed between the two plates of the load frame. The sample was then compressed at a speed
of 2 mm/sec to 70% of the total length. The compression force was recorded, and the column
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length change caused by the compressing was measured. The following equations were used
to estimate the tensile modulus and compression modulus of the whole cryogels:
Strain =ΔL/L Stress=F/A

E=(F/A)/(ΔL/L)

Where E is the Young’s modulus of elasticity, F is the applied force, A is the crosssectional area of the sample, L is the initial length of the sample, and Δ L is the change in length
under tensile and compressive forces. The linear region of the stress vs strain graphs was
analyzed to obtain the elastic modulus for each sample. Three replicates per cryogel were
analyzed, and the elastic modulus values were expressed average ±SD.

A

B

Figure 3. Mechanical strength test on double network cryogels. A) tensile test (left image) B)
compression test (right image).
2.3.4. Swelling kinetics and degradation test
The swelling kinetics were measured using a conventional gravimetric method.2 Briefly,
each cryogel sample was cut to a length of 2.5 mm with a diameter of 12 mm and dried. Dried
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cryogels samples were placed in phosphate buffer saline (PBS) (with 2 mM CaCl2) and
maintained at room temperature (RT). The water absorption rate was measured by weighing
the samples at regular time intervals and calculating the change in weight over time. The
cryogels were removed from the swelling medium at 2 min, 5 min, 30 min, 1 h, and 1 day. The
excess water on the surface was wiped off by the filter paper. After regular intervals, the weight
of the gels was taken until equilibrium was reached. Three replicates of similar size, per
cryogel, were used for the study. The water uptake capacity of the cryogels was determined
using the formula:
Water uptake capacity (Wu) (%) formula:
Wu = [(Mt-Mg)/(Mg)] *100
Wu is water uptake capacity, Mt is weight of cryogels at a given time interval, Mg is weight of
air dried cryogels.
The degradation rate of the cryogels was measured in a similar manner as the swelling
kinetics. Briefly, it involved measuring the change in dry weight of the cryogel at regular
intervals after maintaining them in PBS at 20 °C. Different hybrid DN cryogels and SN
cryogels were vacuum dried overnight with a lyophilizer, and then kept in a vacuum dryer until
further use. The dried cryogels were swelled in PBS either containing 2 mM CaCl 2 or 10 mM
EDTA to chelate calcium. Each cryogel sample had a length of 2.5 mm and a diameter of 12
mm. Hydrogel samples of similar compositions made at room temperature were used as
control.
Degradation (%) formula:
Degradation (%) = (Mt-Mi)/(Mi*100)
Mt is the weight of cryogels at a given time interval, Mi is initial weight of cryogels.
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2.3.5. Rheometer test
All rheology experiments were performed using a temperature-controlled lower peltier
plate geometry rheometer (TA instruments DHR3). For rheological testing, 8-arm PEG
acrylate-DTBA with alginate DN cryogels, 8-arm PEG acrylate-PEG dithiol add alginate DN
cryogels and 8-arm PEG acrylate-PEG dithiol SN cryogels were fabricated into 12 mm
diameter and 5 mm thick disks. The disks were equilibrated in 1× PBS, pH 7.4 for 2 hours at
37 °C. Excess water from the surface of the cryogel was wiped off using KimWipe® prior to
measurement. All cryogels were tested at a frequency of 1 rad s-1 and a constant strain of 1%
(in the linear viscoelastic region).
2.3.6. Chondrocyte isolation and seeding on cryogels
Freshly sacrificed mice (n =20) were obtained from the Syracuse University animal
facility. Mice knees were isolated, and the knee articular cartilage was harvested and then
washed with PBS. The cartilage was then placed in 3 mg ml

-1

collagenase D solution for

digestion, 36, for 45 minutes (Figure 4). The collagenase solution was then diluted to 0.5 mg
ml

-1

with the cartilage still in the solution. The solution was incubated overnight, in an

incubator maintained at 37 °C and 5% CO2. The cartilage disintegrated into smaller aggregates
and individual cells. The next day, the digestive solution with residual cartilage was taken out
and placed in a tube, then centrifuged to obtain a cell pellet of chondrocytes. The chondrocytes
were resuspended in the Dulbecco’s modified eagle medium (DMEM) complete cell culture
medium with 10% fetal bovine serum (FBS) and 1% penicillin streptomycin (PS) with Lglutamine. The chondrocytes cells were plated in a tissue culture treated polystyrene (TCPS)
petri dish and cultured in an incubator maintained at 37 °C and 5% CO2 until used.
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Freshly prepared cryogels were sterilized with 70% ethanol, cut into 4 equal parts inside a
biosafety cabinet. After the evaporation of ethanol completely dried the cryogels, they were
placed in a well of a 48 well plate. Previously isolated and cultured mouse chondrocytes were
resuspended following detachment using trypsin. The chondrocytes were resuspended in
complete medium and 300 μL of chondrocyte suspension was added to each cryogel sample
with 200000 cells/gel. Chondrocytes seeded onto well plates directly were used as positive
control. The chondrocytes were maintained for 10 days and then used for further quantification
of sGAG secretion by chondrocytes.
2.3.7. Measurement of sGAG secretion
After culturing for about ten days, the cryogels were removed from the culture medium
and collected. The cryogels were chopped into smaller pieces and incubated in a papain
digestion buffer and a alginate lyase. The samples were placed in a heating block maintained
at 60-65°C for at least 4 hours to completely dissolve the cryogels. The digested samples were
stored at -80 °C and were subsequently used for sGAG measurement.
The sGAG concentration in cryogel samples was measured using dimethylmethylene blue
(DMMB) assay. A DMMB stock with 2 different concentrations 34 mg/ml and 16 mg/ml was
prepared in 100% ethanol. The stocks were then diluted in a buffer and the pH was adjusted to
1.5. The DMMB dyes solution made from two different stock concentrations were mixed at
fixed ratios and a baseline OD at 525 nm is adjusted to fall between 0.3<OD525<0.34. Next,
chondroitin sulfate standards were prepared in the papain digest buffer. Twenty microliters of
samples and standards are placed in 96 well plates and mixed with 300 μl of the DMMB dye.
The colorimetric change was immediately recorded at 525 nm using a plate reader. The OD of
samples was compared to the chondroitin sulfate standards to determine the concentration of
sGAG formed in each cryogel sample.
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Figure 4. Cartilage harvested from mice knee incubated in collagenase solution for digestion.

3. Results
3.1. Synthesis of cryogels
In this study, we first optimized different parameters for cryogel synthesis. Some of the
different parameters that we studied are listed in Table 3.
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Table 3. Different synthesis parameters for cryogels that were evaluated in this study.
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The first parameter we studied was the synthesis temperature of DN cryogels. Temperature
is a critical parameter for synthesis of cryogels. Cryogels are made at sub-zero temperature as
described in the introduction. The lower the freezing temperature, the smaller the ice crystals
are, and smaller the pore size. Besides, the rate of reaction is also influenced by the temperature
chosen for cryogel formation. Below certain temperatures, the rate of reaction becomes
impractically slow, leading to no crosslink/gel formation.78, 82, 94 Thus, based on these limits
we choose three different synthesis temperatures -8°C, -12°C, and -20°C for synthesis of
cryogel. Qualitatively, comparing the physical appearance (opaque vs translucent) and
mechanical integrity, based on touch of DN cryogel synthesized at different temperatures,
showed that -20°C is the optimum temperature for cryogel synthesis.
Next, we optimized the concentration of two networks and the crosslinking agent
concentration. The first network we tried was 1% or 1.5% w/v alginate. When alginate solution
concentration exceeds 1.5%, the alginate solution becomes excessively viscous and cannot be
used to synthesize cryogels. Thus, we used only 1% w/v alginate for cryogels. In the case of
the alginate network, we initially used CaCl2 as the crosslinker initiator. However, due to the
very fast kinetics of reaction it was difficult to control gelation of alginate before freezing.
Thus, we switched to CaCO3 and gluconolactone (GDL) as the crosslinker initiator for the
alginate network. The CaCO3 and GDL pair allows slow gelation (15 to 30 min depending on
molar concentration) of the alginate network. The slower kinetics allowed us enough time to
work with our solution before freezing them for gelation.
For the second network, we used 10% and 20% w/v 4-arm PEG acrylate (10 kDa) and 8arm PEG acrylate (20 kDa). It was found that when using 4-arm PEG acrylate as the second
network to synthesize DN cryogels with 1% alginate, a 20% w/v concentration of multi-arm
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PEG acrylate was most optimal for synthesis. However, we observed that DN cryogels
synthesized using 4-arm PEG acrylate (10 kDa) and 8-arm PEG acrylate (20 kDa).
Further, to obtain the interconnected macroporous structure, we added different additives
which interfere with ice crystal formation. One of the challenges that we faced in generating
cryogels using the Michael addition reaction for the PEG network formation, was the lack of a
macroporous structure. We postulated that this may be due to high concentrations of both
alginate and PEG. Both PEG and alginate are known to interfere with the formation of ice
crystals, thus their combined presence depresses the temperature for ice crystal formation and
further inhibits ice formation at -20 °C, leading to a non-porous network. Thus, to induce
formation or to manipulate ice formation, we tried 2 different additives: dimethyl sulfoxide
(DMSO) and kaolinite. Kaolinite’s surface is known to promote ice nuclei formation and thus
can help in ice nuclei formation in our system.95 DMSO is a cryoprotectant solvent but also
freezes at a much higher temperature.96 Thus, it may help in ice crystal formation at a much
lower temperature. However, we saw only a modest increase in porosity of these gels post
addition of either DMSO or kaolinite. Only when both DMSO and kaolinite were combined
did we obtain optimal porosity.
Last, we made cryogels using 8-arm PEG acrylate (10 kDa) instead of 20 kDa MW. The
hybrid DN cryogels, made using 8-arm PEG acrylate, as one of the networks resulted in the
formation of macroporous structures, as can be seen in the SEM images. The macroporous
interconnected structure was not obtained when using 4-arm PEG acrylate (10 kDa) and 8-arm
PEG acrylate (20 kDa) as one of the networks (Figure 5). We believe that the MW of the PEG
precursor played a critical role in ice crystal formation. Use of the small molecular weight PEG
precursor, did not inhibit ice formation as much and thus we were able to obtain a macroporous
structure. At this stage we also tested multiple multi-arm thiol crosslinkers (4-arm: 4-arm PEG-
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SH, 3-arm: pentaerythritol; and dithiol crosslinkers: DTT, DTBA and PEG dithiol). We chose
a 4-arm crosslinker to react with a 4-arm PEG acrylate, as studies have shown the formation of
more homogenous and tougher networks if the 4-arm crosslinker is combined with the 4-arm
PEG acrylate.97 However, we had limited success in obtaining cryogels with 4-arm or 3-arm
thiol crosslinkers. Finally, we tested a series of dithiol crosslinkers as listed in Table 1. These
crosslinkers resulted in the formation of cryogels of varying strength and were optimized for
further use. To conclude, in this study, we found that the optimal composition of hybrid DN
cryogels was 1% w/v alginate crosslinked with CaCO3 and GDL + 20% w/v 8-arm PEG
acrylate (10 kDa) crosslinked with dithiol crosslinkers.

A

B

Figure 5. Images of cryogels which did not result in a macroporous structure with adequate
mechanical integrity: A) the shape of cryogels is irregular with no mechanical integrity, B) or
the crosslinking reaction was not efficient, and gel is a liquid after incubation under frozen
conditions.

3.2. SEM analysis of macroporous structure of cryogels
SEM image shows the pore structure of cryogels in Figure 6. We found that the DN
cryogels prepared with 8-arm PEG acrylate have a macroporous interconnected structure
(Figure 10 A&B) with a pore size range of 10-50 μm. Contrary to this the DN cryogels prepared
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with 4-arm PEG acrylate do not show a macroporous structure (Figure 6 D). The structure of
8 arm PEG SN cryogels is porous (Figure 6 E&F), but does not seem to have pore
interconnectivity. The macroporous structure in cryogel is formed as a result of the
polymerization of gel precursors around the frozen ice crystals. Upon thawing, these crystals
melt away, leaving behind an ice-templated macroporous interconnected network. The
difference in pore structure between DN cryogels of 4-arm acrylate and 8-arm PEG acrylate
could be attributed to the MW of the individual arm. As discussed above, PEG inhibits ice
formation.98 The efficiency of cryoprotection action of PEG is dependent on the molecular
weight of PEG. Thus, when we used 4-arm PEG acrylate vs 8-arm acrylate 10 kDa, the
individual MW of each arm changed from 2.5 kDa to 1.25 kDa. We believe that this change
in MW of the PEG precursor played a critical role in facilitating ice crystal formation and thus
the interconnected pore network in DN cryogels. Use of the small molecular weight PEG
precursor did not inhibit ice formation as much and thus we were able to obtain macroporous
structure.99-101 Thus, 8-arm PEG acrylate is more suitable for the network for preparing DN
cryogels. Lastly, use of different dithiol crosslinkers did not affect the pore architecture,102 and
similar pore size and morphology was observed for both DTT and PEG-dithiol crosslinker in
8-arm PEG acrylate+ alginate DN cryogel irrespective of the crosslinker MW.
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Figure 6. SEM images of DN and SN cryogels. A) 8-arm PEG acrylate-DTT+ alginate DN
cryogels; B) 8-arm PEG acrylate-PEG dithiol + alginate DN cryogels; C) 8-arm PEG acrylateDTBA+ alginate DN cryogels D) 4-arm PEG acrylate-DTT+ alginate DN cryogels; E) 8-arm
PEG acrylate-DTT SN cryogels; F) 8-arm PEG acrylate-DTBA SN cryogels.

3.3. FTIR analysis of cryogels
FTIR images of the DN cryogels and SN cryogels is shown in Figure 7 A & B.
Comparing the FTIR diagrams of DN cryogels, I found 8 arm PEG acrylate-PEG dithiol with
alginate DN cryogels and 8 arm PEG-DTT with alginate DN cryogels have a peak at 3330
cm-1 and 1610 cm-1. The peak at 3300 - 3400 cm-1 is a result of -OH stretching in alginate
while the 1610 peak is a result of stretching vibrations of the carboxylate anions.103 The peak
corresponding to C=O is seen at 1732 cm-1 in both SN and DN cryogels, showing that both
PEG and alginate have incorporated in the DN network. In SN PEG cryogels the peak
corresponding to C=C at 1610 cm-1 is not seen owing to a formation addition reaction
between C=C of 4-arm PEGAc and SH of the dithiol crosslinker. The peak at 1610 cm-1
reappears in the DN because of the presence of the -COOH in alginate. These peaks prove
that the DN cryogel has carbonyl and hydroxyl groups, which are present in the alginate
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chain and the PEG acrylate reaction with thiol forms the second network. By FTIR spectra
we demonstrated that DN cryogels contain alginate but SN cryogels do not.

Figure 7. Comparing ATR-FTIR spectra of DN and SN cryogels of PEGacrylate-dithiol and
alginate. A) 8-arm PEG acrylate-PEG dithiol with alginate DN and 8-arm PEG acrylate-PEG
dithiol SN; B) 8-arm PEG acrylate-DTT with alginate DN and 8-arm PEG acrylate-DTT.
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3.4. Tensile test and compression test of cryogels
In the tensile test, when the applied force increased, the trend changed from an upward to
a flat trend, indicating that the cryogel was stretched to the endurance limit and broke. From
the tensile test analysis, it can be seen that SN cryogels break at a greater tensile force, so they
have stronger mechanical properties (Figure 8). The elastic and compressive properties of
cryogels are determined by applying physical stress to the gel, which in turn is used to calculate
Young's modulus, which is a mathematical description of the tendency of an object or substance
to deform when a force is applied to it. Figure 8 shows the tensile Young's modulus of each
cryogel sample of the same size, calculated by analyzing the stress and strain values for each
cryogel. The calculated tensile modulus of 8-arm PEG-DTT with alginate DN cryogels is
around 305.5 kPa. This is lower than that of 8-arm PEG-DTT SN cryogels, which show a value
of around 738.2 kPa.

29

A

B

C

Figure 8. Tensile testing of the cryogels: A) Tensile strength of DN 8-arm PEG -DTT with
alginate cryogel and SN 8-arm PEG-DTT. B) Analysis of the tensile test strain-stress data to
obtain Young’s modulus data. C) Comparison of double network cryogels and single network
cryogels tensile test Young's modulus

The compression analysis of hybrid DN cryogels shows a sudden drop from an upward
trend, which means that the cryogels when compressed beyond 50% of original length are
broken. From the compression test, it can be seen that under the same pressure and deformation,
the SN cryogels are not broken, but the DN cryogels have broken (Figure 9). 8-arm PEG-DTT
with alginate DN cryogels ruptured at 70% strain compared to 8-arm PEG-DTT SN cryogels

30

which were able to regain shape after compression. It is observed that 8-arm PEG-DTT with
alginate DN cryogels require less stress to undergo compression than 8-arm PEG-DTT SN
cryogels, suggesting that 8-arm PEG-DTT SN cryogels are more elastic and mechanically
stronger, while DN cryogels are mechanical weaker.

B

A

C

Figure 9. Compression testing of the cryogels. A) Compressive strength of DN 8-arm PEG DTT with alginate cryogel and SN 8-arm PEG-DTT. B) Analysis of the compressive test strainstress data to obtain Young’s modulus data.
According to the results of the tensile test and compression test, we found that SN cryogels
have higher tensile and elastic modulus than the DN cryogel. This may be related to the
difference in porosity and pore network in DN cryogel and SN cryogel. At the same time, the
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addition of alginate may affect the mechanical properties of DN cryogels to some extent and
the mechanical strength of DN cryogels prepared with alginate may be insufficient.

3.5. Swelling kinetics and degradation rate of cryogels
The swelling kinetics of SN and DN cryogels is shown in Figure 10. In the test, the time
required to reach equilibrium value of water uptake capacity was determined for each cryogel.
All SN and DN cryogels reach > 80% Wu in 2 min after incubation in the aqueous buffer. Both
SN and respective DN cryogels have similar swelling kinetics and all cryogels reach close to
equilibrium swelling within 30 min. After 30 min, the change in the water uptake capacity of
cryogels is minimal. The water uptake capacity of 8-arm PEG acrylate-DTT cryogels always
remains at the same level of 89% after 2 min. The water uptake capacity of 8 arm PEG acrylate
with SH-PEG-SH cryogels is moderate in the initial stage, and the water uptake capacity
gradually increases over time but the equilibrium swelling time remains 30 min. The water
uptake capacity of 8-arm PEG Acrylate + DTBA cryogels was slowest in the initial stage, and
it increased rapidly over time, and reached to 88% Wu at 24 h. The differences in the swelling
kinetics of the cryogels indicate differences in the pore interconnectivity and crosslinking
density/efficiency. A faster swelling equilibrium but comparatively lower Wu in 8-arm PEGDTT DN and SN gels shows higher crosslinking density of the gels with a highly
interconnected pore network, which facilitates faster water uptake in the network. Conversely,
slower water uptake in 8-arm PEG-DTBA DN and SN gels show high crosslink density and
lower pore interconnectivity which decreases the water uptake rate. Nonetheless, the faster
equilibration of the cryogels with the surrounding medium makes them an excellent scaffold
for cell culture. The faster swelling kinetics indicates pore interconnectivity and an open pore
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structure. Both features facilitate cell infiltration as well homogenous transport of the nutrients
within the scaffold.

Figure 10. Water uptake capacity of different DN and SN cryogels.
Degradation kinetics of cryogels was studied in phosphate buffer at room temperature.
Figure 11A shows the degradation of different DN cryogels in the presence of 10 mM EDTA
in the medium incubated at room temperature. 4-arm PEG acrylate-DTT with alginate cryogel
seemingly has a faster degradation rate than 8-arm PEG cryogels. However, after degrading
to 25% the rate of degradation becomes extremely slow. Among 8-arm PEG acrylate cryogels
, DN cryogels with DTBA as a crosslinker has the slowest degradation rate while the dithiol
containing 8-arm PEG acrylate gels have the fastest degradation. Nonetheless, cryogel
degradation is ~5-25% in over 25 days, which is much slower than expected. Previous studies
of PEG hydrogel using these dithiol crosslinker shows a degradation time of 8 to 20 days for
4-arm PEG acrylate hydrogels. Thus, based on these reported times, we expected significant
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degradation of the cryogels when incubated in PBS at room temperature. To understand the
differences in expected degradation time from observed degradation time, we further
conducted degradation studies using a few of the DN hydrogels (Figure 11 B). In these studies,
in order to simulate similar conditions to cryogels, the hydrogels were dried completely and
then incubated in the PBS with 2 mM CaCl2. We observed that the DN hydrogels absorbed
slowly and the degradation increased gradually over a period of 25 days. However,
unexpectedly, the DN hydrogels only degrade by 25% in 25 days. We believe this is due to
slow penetration of water into the network and presence of alginate in DN. Both decreased the
rate of degradation at room temperature. Lastly, the cryogels’ degradation was accelerated
when incubated in FBS containing medium at 37 °C. We observed that on day 15, 4-arm PEGDTT with alginate DN cryogels and a small portion of the 8 arm PEG-DTBA with alginate DN
cryogels degraded. On day 18, most of the 8-arm PEG-DTBA with alginate DN cryogels and
a small part of the 8-arm PEG-DTBA SN cryogels were degraded. On day 21, most of the 8arm PEG-DTBA SN cryogels were degraded. A small fraction of 8- arm PEG-PEG dithiol with
alginate DN cryogels was degraded on the 24th day, while on Day 27, most of the 8-arm PEGPEG dithiol with alginate DN cryogels was degraded. Further quantitative studies are required
to confirm the degradation rate of the cryogels at 37 °C.
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Figure 11. Degradation kinetics of cryogels and hydrogels at room temperature. A)
Degradation of cryogels in EDTA containing media; B) Degradation of hydrogels in PBS with
2 mM CaCl2.

3.6. Rheological analysis of DN cryogels
Viscoelastic properties of cryogel were investigated using rheometric measurements
(Figure 12). By comparing the storage modulus of 8-arm PEG acrylate-DTBA with alginate
DN cryogels and 8 arm PEG acrylate-PEG dithiol with alginate DN cryogels, it was found that
cryogels with low MW cross-linking agent (DTBA) have higher storage modulus than those
using a high MW crosslinker (PEG dithiol). By comparing the storage moduli of 8 arm PEG
acrylate-PEG dithiol add alginate DN cryogels and 8 arm PEG acrylate-PEG dithiol SN
cryogels, it was found that the storage modulus of SN cryogels is higher than that of DN
cryogels. Our results show that both the chemical structure and the crosslinker MW affect the
storage modulus of the resulting hydrogels.
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Figure 12. Cryogels sample storage modulus data.

3.7. sGAG synthesis by chondrocytes in cryogel constructs.
The standard curve for chondroitin sulfate standard showed linear correlation between
increasing chondroitin sulfate concentration and the OD525 (R^2=0.99). The DMMB assay was
conducted at pH 1.5 to avoid interference from alginate in sGAG readout due to similarity in
structure and ability to react with the dye. Cryogel samples without cells were included as
negative controls to ensure the degree of interference if any from alginate in DMBB assay
readouts. The OD at 525 nm from control cryogels samples of 4 arm PEG-DTT with alginate
DN cryogels and 8 arm PEG-SH-PEG-SH with alginate DN cryogels was close to baseline
indicating negligible interference of alginate in the assay. In cryogels co-cultured with
chondrocytes, the average concentration of 50.48 μL/ml in 8-arm PEG -DTBA with alginate
DN cryogels (Figure 13). While the average concentration sGAG was 24.42 μL/ml and
22.30μL/ml for 8 arm PEG -DTBA SN cryogels is, and 8 arm PEG –PEG dithiol with alginate
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DN cryogels respectively. The 4 arm PEG -DTT with alginate DN cryogels showed the lowest
amount of sGAG accumulation with an average concentration of 11.70 μg/ml. The
chondrocytes cultured on TCPS were included as positive control and secreted about
19.27μg/ml sGAG during the test period. The experiment shows that macroporisty played an
important role in increasing sGAG secretion as the sGAG secretion was highest in 8-arm PEG
acrylate DN cryogels compared 4-arm acrylate DN cryogels which were non-porous in nature.
However, further normalization of the data to the cell number or DNA content is required
before making any further conclusions. Additionally, the difference in mechanical properties
of cryogels also needs to established to conclusively determine the role of porosity in ECM
accumulation.

Figure 13. A) Chondroitin sulfate standards; B) Concentration of sGAGs in different kinds of
cryogels.
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4. Limitations of the Study
In this study, we combined 4 arm PEG acrylate/ 8 arm PEG acrylate with alginate to
synthesize hybrid DN cryogels. The goal was to generate a tough interconnected porous
network to be used as a substrate chondrocyte culture, and eventually cartilage repair. By
modifying the various conditions of synthesis such as temperature, concentration of monomers
and their molecular weight, we established conditions which generated macroporous cryogels.
One of the novelties the cryogels generated in the study is use of chemical reactions which are
non-toxic and do not generate any harmful chemical initiators. Previous studies used these
polymer combinations to generate a DN employed free radical polymerization which required
toxic initiators for crosslinking reactions.
After successfully establishing the conditions for cryogel synthesis, a series of
characterizations were performed on DN cryogels. These characterizations revealed the
macroporous structure, a fast-swelling rate, a very slow degradation rate and mechanical
properties of DN cryogels. However, some of the methods used for characterization as well as
sample size included in these characterizations were not appropriate. Thus, we have identified
some specific limitations for each of the characterizations and identified what future work is
required to establish conclusive data for each property. Some of the specific revisions to each
of the methods in the current work are described below.
A.

Pore size quantification and pore interconnectivity measurements
The pore size of the synthesized cryogel was estimated based on the SEM images. The

primary deficiency here is that pore size range was not measured accurately. Further only the
upper and lower surfaces of the cryogels were photographed with SEM, and a cross-sectional
image of cryogels was not obtained. Estimation of pore size by SEM imaging is very
approximate and thus, measuring pore size across replicate samples for different cryogels is
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required to establish an accurate pore size range. We will also get additional SEM images of
the cross-sectional surface of cryogels to establish the presence of pores throughout the
network. We will use Image J to measure pore size across different cryogel samples. Briefly,
each image will be thresholded in Image J and the scale bar will be calibrated to image pixel
size. 100 random pore diameters and areas will be determined by measuring the long diameter
of each pore and tracing the outer edge of the pore, respectively. The average pore sizes from
three replicate samples for each type of cryogel will then be reported. We will also determine
the distribution of pore sizes in different cryogels and the pore sizes of cryogels prepared using
different cross-linking agents will be further compared.
The presence of an interconnected open porous network in cryogels was indirectly deduced
from the fast-swelling rate and short swelling equilibration times. However, to establish pore
interconnectivity experimentally, we need to perform a set of experiments. First, we can study
protein diffusion through cryogels and determine their relative diffusivity in cryogels. If the
protein diffusivity in cryogels is equivalent to their diffusivity in the water, this can be an
indirect measurement of the high porosity of cryogels. It also means that the pores are highly
interconnected, which provides a continuous network of the aqueous medium in which the
protein can diffuse. In a second experiment, we can determine the hydraulic permeability of
the cryogels. Hydraulic permeability will allow us to characterize the convective transport of
the water through cryogels. If the cryogels form a continuous network of capillaries due to pore
interconnectivity the hydraulic permeability of the cryogels will be high.
B. Mechanical testing of cryogels
In the following study, we characterized various tensile and compressive properties of
cryogels in order to establish their application for cartilage tissue engineering. For both tensile
and compressive tests, hybrid DN cryogels formed using different dithiol crosslinkers (DTT,
DTBA and PEG dithiol) and were included for comparative analysis. Further, a sample size of
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3 was required for each of the cryogels. A major flaw for both of the tests was that cryogels
were not pre-equilibrated in the buffer before testing. Thus, all tests should be repeated where
the sample is equilibrated in buffer for 2- 4h and then the compression or tensile test should be
performed.
The tensile test was performed on cylindrical samples. However, as per ASTM standards
and current standard methods for tensile testing the sample should have been dumbbell shaped.
Thus, the experiments should be repeated using dumbbell shaped cryogel samples. The sample
dimension for tensile testing according to ASTM-D638-V will have a length 63.5mm, width
9.53mm, gauge length 9.53mm, gauge width 3.18mm (Figure 14)

Figure 14. Dimension of dumbbell shaped sample for tensile testing of cryogel samples.
To conduct the tensile testing on cryogels the samples will be cut into dumbbell shapes
with the dimensions described above. The samples will be equilibrated in a buffer for 2-4 h and
then positioned in a uniaxial tensile tester with a load cell of 25 N. In the previous data the rate
of applied stress was relatively fast, which may have influenced the quality of the data we
collected. Thus, in the proposed set of experiments we will run the tensile test at 5 mm/min.
The scaffold thickness and grip distance will be measured and taken into account before testing
the sample. A stress-strain curve so generated will be used for analysis. The linear region of
the curve will be used to derive the Youngs modulus of the cryogels samples. To maintain
uniformity, the linear region of the curve will be analyzed at a 10% strain across all samples
and replicates.
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Compression testing procedures for cryogels in future experiments will be done as
described in the Materials and Methods section, but with a few changes. The load cell used for
these studies will be 100 N and force will be applied at a rate of 5 mm/min up to 70%
compression. The samples will be pre-equilibrated in buffer before testing. The linear region
of the stress strain curve will be analyzed at 10% strain to obtain Youngs modulus.
Lastly, for determining the storage modulus of the cryogels, the cryogels will be presoaked into buffer and then used for analysis. Additional samples of cryogels with different
crosslinkers will be consistently included across all tests.
C. Analysis of sGAG secretion in cryogel constructs
The data included for sGAG quantification across different samples of cryogels needs to
be normalized to DNA content across each sample. We will analyze the lysate from each
sample using a pic-green assay to account for variation in cell number across samples and to
normalize the value of sGAG secretion. The normalized data can then be used for reaching
further conclusions and for the design of experiments.

5. Future work
Future studies will focus on improving the mechanical strength of the DN cryogels. We
will test different experimental conditions to achieve this goal. To strengthen the cryogels, we
will: 1) use new crosslinkers; 2) change the concentration of polymers and crosslinkers; and 3)
repeat freeze thaw cycles. Next, I hope to test the injectability of these cryogels. We will also
conduct a series of biological tests to test chondrocyte behavior when cultured on these cryogel
scaffolds. Finally, the optimized cryogels performance will be tested in an animal model
cartilage defect (Figure 15).
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Figure 15. Future works for making cryogel to repair cartilage defect.
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Chapter 2
Developing Mice Model of Post Traumatic Osteoarthritis
1. Introduction
After suffering a traumatic joint injury (such as anterior cruciate ligament (ACL) or
meniscal injury), approximately half of patients will continue to develop post-traumatic
osteoarthritis (PTOA) within 10-20 years.104-105 This increases the risk of OA development not
only in older age groups, but in young people or athletes who suffer from traumatic joint
injuries. The research on PTOA106 has been highly valued by scientists. The newly developed
PTOA non-invasive tibial compression model developed by scientists in recent years can
accurately capture some of the characteristics of traumatic joint injuries that are typically found
in PTOA in humans. The non-invasive model can use externally applied mechanical loads to
simulate a traumatic injury without the need for surgical intervention. Therefore, the noninvasive injury model is completely sterile, avoiding potential infections and other problems
caused by the trauma of surgery/invasive injury surgery.107 After tibial compression, the knee
joint shows increased anterior and posterior joint laxity.108 Synovial inflammation occurs
within 3-5 days after injury and lasts for 8 weeks.109-110 In addition, it has been reported that
the intracellular activation of NF-κB in cartilage occurs 12 hours after mechanical injury in the
PTOA mouse model.111 It is well established that NF-κB activation plays a crucial role in the
early development of PTOA and regulates inflammation. Here in this study, we established the
non-invasive tibial compression mouse model of PTOA. We characterized anterior-posterior
joint laxity post loading to establish the reproducibility of our method.
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2. Materials and methods
2.1. Anterior cruciate ligament rupture using cyclic mechanical loading
We obtained freshly sacrificed mice (male, 9-12 weeks old, n=20) from the animal facility.
The cadaveric mice knees were then mechanically loaded on randomly assigned knee joints to
induce anterior cruciate ligament (ACL) rupture using the Instron machine. Briefly, mice
cadavers were laid flat on a platform, and then the mice knees were positioned at 90 degrees in
a 3 points bending mode between two customized cups. Each cup was designed to hold the
knee and paw respectively. Thus, one cup was arc-shaped, and the other end was wedge-shaped
(Figure 17) 40 sets of mice knee joints underwent cyclic mechanical overload (12N axial
compression load for 60 cycles). The mice were randomly assigned to three groups including
a sham control (CTRL, n = 6), joint injury (INJ, n = 13). Only one of the knees underwent
mechanical loading in each mouse while tbe others were used as contralateral controls. Post
mechanical loading, the hind limbs were dissected, and three unknown investigators rated
anterior and posterior laxity (0 = naive, 1 = increased anterior and posterior laxity). The total
score for each joint was calculated, and the CTRL and INJ joint scores were compared using
the Mann-Whitney test.112
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Figure 16. The shape of the screws and the diagram of the instron machine that destroys the
mice joint.

3. Results
3.1. Laxity test
The cyclic mechanical loading of the cadaveric mice knee joint consistently induced ACL
rupture. This was evident from the force displacement curve whereby a pop sound was heard
upon ACL rupture and a drop in the force displacement curve occurred. The induction of ACL
ruptures by mechanical loading was also confirmed by conducting the laxity test. The three
blinded investigators reported a score zero for 10 knees, a score of 1 for 3 knees, and a score
of 3 for 19 knees (Figure 18). Some of the knees were excluded from analysis as the femur of
was damaged when the mice joint was mechanically loaded. The laxity test further established
that the mechanical overload can reproducibly induce ACL rupture. This indicated the
suitability of the method for induction of ACL ruptures and using this method to establish
mouse models of PTOA via non-invasive trauma to the joint.
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Figure 17. Average Laxity test scores reported by three blinded investigators.

4. Conclusion
In animal experiments, laxity tests proved that mechanical loading led to an increase in
joint laxity, indicating ACL rupture. We conclude that this method can reliably be used to
establish a non-invasive mouse model of PTOA. Our results are in line with previous reported
studies which used a similar model of PTOA.109,

113

Further studies will include pain

measurements and histological analysis to monitor development and progression of PTOA in
mouse models after ACL-rupture.
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